深圳市博大生物技术有限公司

Shenzhen Boda Biotechnology Co., Ltd., established in 2004, is primarily engaged in the research and development of specialty intermediates and active pharmaceutical ingredients (APIs). We operate two R&D centers and three GMP-compliant factories equipped with capabilities for biotransformation and chemical synthesis. Boda has established strategic partnerships with many renowned pharmaceutical companies, serving as their supplier of intermediates and APIs. Examples include: Desogestrel, Drospirenone, Dydrogesterone, Eplerenone, Daunorubicin, Epirubicin, Everolimus, Mupirocin, Mupirocin Calcium, Sitagliptin, Vildagliptin, Sevelamer Hydrochloride, Polymyxin Sulfate... DMF files for some products are already prepared, while for others, they are in preparation. We are open to various forms of cooperation with friends both domestically and internationally.